In this episode of the DTx Podcast, Eugene Borukhovich sits down with Mike Pace, CEO and founder of PalmHealthCo, to delve into the latest developments and insights from the DTx industry from 2023 and to discuss what may be in store for 2024. Eugene and Mike cover various aspects of the DTx landscape, including the growing importance of FDA authori…

In this episode of the DTx Podcast, Eugene Borukhovich hosts Philip Heimann, CEO of Vivira, a prominent player in the DTx landscape in Germany. "The genesis of Vivira was the need for personalized movement therapy - we wanted to provide people with a solution that was made just for them," says Philip. This necessity led to the development of an inn…

In this episode, we hear from Josh Sackman, President and Co-founder of AppliedVR. AppliedVR, in their own words, provide virtual reality-based treatments that represent a comprehensive approach to chronic pain that empowers patients with accessible digital tools self-managed in their own home. In this episode, we cover: The origin story of Applied…

In this replay episode, we hear from Sylvain Piquet, COO and Co-founder of Five Lives, the app that leverages the new science of brain aging, neuroplasticity, and cognitive reserve to help people improve their brain health and prevent cognitive decline and dementia. In this episode, we cover: The origin story of Five Lives and the motivation behind…

In honor of Gift of Sight month we're replaying this insightful episode with Mark Wuttke, CEO of Dopavision. In their own words, Dopavision is pioneering the development of innovative solutions that target the eye’s innate dopamine pathway to address unmet needs in ophthalmology using digitally delivered light. Topics include: The background to Dop…

In this episode, we hear from Vijay Ravindran, founder and CEO of Floreo. Floreo allows therapy to be more engaging and happen anywhere, assisting people in practicing critical social skills at their own pace through immersive experiences, starting with adolescent Autism spectrum disorder. In this episode, we cover: The founding story of Floreo Mar…

We're seeing a broader consolidation of digital health solutions this year to bring together the amazing talent and the scientifically validated assets to drive scale in the market and improve unit economics. On the heels of last week's announcement of the merger between Fern Health and BehaVR tune into this replay episode to hear Eugene Borukhovic…

In this episode, we hear from, Rich Brancaccio, Chief Innovation Officer of Revibe Technologies, and Lindsay Ayearst, Chief Scientific Officer of Revibe Technologies. In their own words, Revibe is a digital therapeutics company fusing behavioral science with technology and currently developing a new digital therapy for ADHD. In this episode, we cov…

There are two kinds of people in the world, says Brent Vaughan — those who prefer to make incremental changes with a lower likelihood of failure, and those who aspire to fix (seemingly) intractable problems that have stymied others. Brent falls in the latter category. A serial entrepreneur, former venture capitalist, and current CEO of Cognito Ther…

In this episode, we hear from Chan Yoon, MD, CEO of EverEx. EverEx is revolutionizing musculoskeletal rehabilitation with cutting edge AI, pose estimation technology, and evidence based treatments. In this episode, we cover: Insights into Digital Health in South Korea The EverEx creation journey The musculoskeletal health market in South Korea Fund…

Cognitive behavioral therapy (CBT) is an evidence-based form of therapy that has been in use for decades. My guest in this episode believes that CBT can be applied to create better therapeutics, and, in fact, that’s exactly what his company is called: Better Therapeutics. Dr. Mark Berman, the Chief Medical Officer at Better Therapeutics, explained …

In this episode, we hear from Francesca Wuttke, Founder and CEO of Nen who is focusing on building prescription digital therapeutic at a cross-section of pediatrics, pain with an initial focus in oncology. In this episode, we cover: The background to nen and naming the company Gamifying CBT for treating children's pain Targeting the psychological a…

Curio has announced positive data from the Supporting Maternal Mental Health and Emotional Regulation (SuMMER) trial demonstrating that MamaLift Plus has met its efficacy endpoints. This is a significant step towards providing better support for mothers during a crucial time. In this Replay episode we hear from Shailja Dixit, CEO of Curio. In their…

In this special feed drop hear Eugene Borukhovich in conversation with Pharmaphorum Editor in Chief Jonah Comstock discussing what they saw and heard at DTx East in Boston. This year the digital therapeutics space took a hit with the downfall of Pear Therapeutics, one of the most well-known of the industry’s still-active pioneers. Combined with Aki…

In this episode, we hear from Mark Wuttke, CEO of Dopavision. In their own words, Dopavision is pioneering the development of innovative solutions that target the eye’s innate dopamine pathway to address unmet needs in ophthalmology using digitally delivered light. Topics include: The background to Dopavision The pediatric Myopia vs adult Myopia ma…

In this episode, we hear from Andrew Jenkinson and Niall O'Driscol, CEO's and Co-founders of vStream. vStream's primary focus is on the creation of compelling and engaging patient-centric experiences. Specializing in virtual reality, augmented reality, mixed reality, 360 video, immersive experiences, and digital installations Topics include: The ba…

If you’ve been keeping up with the news you’ll know that since March this year, Kranus Edera has been permanently listed as a digital health application by the Federal Institute for Drugs and Medical Devices. But the journey did not stop there. Last week Kranus Health achieved another milestone: successful price negotiations with the GKV-Spitzenver…

In this episode, we hear from Meri Beckwith, Co-founder of Lindus Health. In their own words, Lindus delivers end to end clinical trials for health tech and biotech pioneers. Topics include: The background and inception story of Lindus Health Lindus Health's place in the value chain Achieving key funding milestones in a difficult market enviroment …

In this episode, we hear from Susa Monacelli, General Manager at Propeller Health. In their own words Propeller Health is a precision digital health company on a mission to uplift every person living with chronic disease so they can take control of their health and live a better life. Topics include: The background to Propeller Health and the ResMe…

Have you heard? On August 22, Mahana Therapeutics announced a distribution and marketing partnership with Bayer’s consumer health division. This partnership unites Mahana’s proficiency in digital therapeutic advancement with Bayer’s commitment to empowering individuals through cutting-edge digital solutions, all aimed at enabling greater personal h…

In this episode, we hear from Brian Wallace, CMO and Co-Founder of Calmsie. Calmsie in their own words are empowering children to develop emotional resilience from an early age. Calmsie creates engaging DTx video games designed to improve outcomes for children with depression and anxiety. In this episode, we cover: Translating addiction science to …

In this special feed drop hear the first episode of Emerging Medtech Today, hosted by Henry Peck and powered by LSI. The Emerging Medtech Today podcast offers a unique opportunity to gain valuable insights from industry leaders who are building breakthrough businesses that are moving medtech forward. Join Henry as he engages in captivating conversa…

In this episode, we hear from David Kim, Managing Director at DigiTx Partners. In their own words DigiTX Partners is a venture firm focused on investing in and supporting early stage startup companies in the digital health space. Launched in 2016 as a joint venture by Astellas Pharma And MPM Capital, DigiTx Partners remains one of a few venture fun…

In this episode, we hear from Sean Khozin, Senior Partner at the investment firm Braven Partners. He focuses on advancing in innovations at the intersection of biology, technology and AI. Sean was previously the CEO of CancerLinQ and the Global Head of Data Strategy and Data Science at Johnson & Johnson. He had a successful tenure in the US federal…

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression. Big Health, the leading provider of non-drug digital treatments for mental health, has now acquired Limbix. In addition to health care providers, SparkRx will be made available to …

In this episode, we hear from Eddie Martucci, co-founder and CEO of Akili. In their own words, Akili Interactive is a leading digital health company combining scientific and clinical rigor with ingenuity of the tech industry to reinvent medicine. In this episode, we cover: What factors have led to the increase in market demand for non-drug treatmen…

Let's face it, entrepreneurship is tough. While we're certainly seeing a much needed correction in the market this does not make it easier for any trailblazers out there. Sales cycles have slowed down. Decision making became even less transparent. And finally, funding became a numbers game. Now add to all of this, some recent bankruptcies and your …

In this episode, we hear from Jennifer Goldsack, CEO of Digital Medicine Society (DiMe). In their own words, DiMe is a global non-profit and the professional home for all members of the digital medicine community. In this episode, we cover: The origin and mission of DiMe Defining digital health, digital medicine and digital therapeutics Collaborati…

In this episode, we hear from Joe Perekupka, CEO of Freespira. In their own words Freespira is 'the only medication-free, FDA-cleared digital therapeutic treatment proven to significantly reduce or eliminate symptoms of panic disorder, panic attacks and post-traumatic stress disorder in just 28 days.' In this episode, we cover: The founding story o…

In this episode, Eugene sits down with Megan Coder, Chief Policy Officer of the Digital Therapeutics Alliance (DTA). Tune in to hear the exciting and positive advancements taking place in the digital therapeutics industry following the DTA Inaugural Summit. Topics include: The success of DTA's first summit in Washington DC Introducing a new definit…

In this episode, we hear from Jenna Carl PhD, Chief Medical Officer at Big Health. Big Health believes in mental health care for all and that their digital therapeutics are safe and effective non-drug options for mental health. In this episode, we cover: Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience an…

In this episode, Eugene Borukhovich sits down with Aaron Gani, Founder and CEO of BehaVR. BehaVR translates proven science into immersive and engaging XR therapeutics for mental and behavioral health. In this episode, we cover: Origin Story: Aaron Gani shares the origin story of BehaVR, starting from its inception in 2016 and the inspiration behind…

In this episode of DTx Podcast, Eugene Borukhovich sits down with Acacia Parks, Founder of Liquid Amber Consulting. Liquid Amber helps digital health and DTx companies support the claims they want to make using scientific evidence, in the ways that will be compelling to the audiences they care about. Topics include: A Day in the Life of a Chief Sci…

In this episode Eugene Borukhovich sits down with Ameya Phadke, Ph.D., Patient Non-Pharma Solutions Leader at Chiesi Group. Join them as they delve into the world of digital therapeutics and explore how pharma companies are embracing digital health to revolutionize patient care. Topics include: The Chiesi Group's History: Discover the largest inter…

In this episode, we hear from Jens Noertershaeuser, Founder & Co-CEO of Kranus Health. In their own words, Kranus Health’s mission is to revolutionize men's health by providing innovative and accessible healthcare solutions. As one of only 10 companies with a permanent approval, Kranus Edera is the only the first digital health app (DiGA) for the t…

In this episode, we hear from Omar Manejwala, MD, Chief Medical Officer at DarioHealth. In their own words, DarioHealth makes it easy for people to care for their health, with continuous and connected support that anticipates needs, understands motivation, and simplifies behavior change to put better health and outcomes in everyone’s reach. In this…

In this episode, we hear from Alberta Spreafico, Global Head of Digital Health & Innovation Strategy at Healthware Group. In their own words, Healthware combines advisory, agency services and technology capabilities to improve health outcomes while delivering transformational business results. In this episode, we cover: The background to Healthware…

In this episode, we hear from Jennifer Goldsack, CEO of Digital Medicine Society (DiMe). In their own words, DiMe is a global non-profit and the professional home for all members of the digital medicine community. In this episode, we cover: The origin and mission of DiMe Defining digital health, digital medicine and digital therapeutics Collaborati…

In this episode, we hear from Benjamin Alouf, MD, Chief Medical Officer at Limbix. In their own words, Limbix is the first digital therapeutic for adolescent depression. In this episode, we cover: Origin of the company and story behind the name 'Limbix' The funding journey and key milestones achieved The choice to focus on the young adult populatio…

In this episode, we hear from Andrzej Jończyk, MD, Co-founder and CEO USA of Prosoma. In their own words, Prosoma develops a portfolio of digital therapeutic medical software products that cover the entirety of behavioral treatment needs of cancer patients. In this episode, we cover: The background to Prosoma The funding journey and milestones reac…

In this episode, we hear from Jason Kahn, Co-founder and Chief Science Officer at Mightier. Mightier, in their own words, is a digital program for kids that uses their heart rate to teach coping skills through game-based play. In this episode, we cover: The founding story and meaning behind the name 'Mightier' Funding journey and key milestones in …

In this episode we hear from Simon Levy, CEO and Co-founder, and Ann Montgomery, Chief Product Officer at Mahana. In their own words, Mahana develops digital treatments for people living with chronic health conditions, and their first treatment, Mahana for IBS, is now available as an FDA-cleared app. In this episode, we cover: The founding story an…

In this special episode of DTx Podcast, Eugene is joined by Brent Vaughan, CEO of Cognito, as well as industry leaders from previous episodes, to weigh in on the recent Pear Therapeutics news and the future of prescription digital therapeutics. In this episode, we cover: The impact on the PDT market Future efforts to move DME to PDT The impact on t…

In this episode, we hear from Josh Sackman, President and Co-founder of AppliedVR. AppliedVR, in their own words, provide virtual reality-based treatments that represent a comprehensive approach to chronic pain that empowers patients with accessible digital tools self-managed in their own home. In this episode, we cover: The origin story of Applied…

In this episode, we hear from Jo Masterson, CEO and Co-Founder of 2Morrow. In their own words 2Morrow's mission is to help millions improve their lives with the use of evidence-based, behavioral change programs. In this episode, we cover: The founding philosophy of 2Morrow and co-founding a company with your partner The funding journey The NIH gran…

In this episode, we hear from Brian Wallace, CMO and Co-Founder of Calmsie. Calmsie in their own words are empowering children to develop emotional resilience from an early age. Calmsie creates engaging DTx video games designed to improve outcomes for children with depression and anxiety. In this episode, we cover: Translating addiction science to …

In this episode, we hear from Sylvain Piquet, COO and Co-founder of Five Lives, the app that leverages the new science of brain aging, neuroplasticity, and cognitive reserve to help people improve their brain health and prevent cognitive decline and dementia. In this episode, we cover: The origin story of Five Lives and the motivation behind focusi…

In this episode, we hear from Hannes Klöpper, CEO of HelloBetter. HelloBetter, in their own words, wants to empower as many people as possible to manage their own mental health and improve their quality of life – anywhere and at any time, without the wait lists. In this episode, we cover: The origin story of HelloBetter, from university research to…

In this episode, we hear from Joe Perekupka, CEO of Freespira. In their own words Freespira is 'the only medication-free, FDA-cleared digital therapeutic treatment proven to significantly reduce or eliminate symptoms of panic disorder, panic attacks and post-traumatic stress disorder in just 28 days.' In this episode, we cover: The founding story o…

In this episode, we hear from Ali Hashemi, Co-founder of meta[bolic]. In their own words, meta[bolic] is a hybrid digital therapeutics company focused on addressing the global metabolic health crisis. In this episode, we cover: The initial business hypothesis of GluCare and meta[bolic] Digital therapeutics vs disease management Why we are becoming …